{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:36:26Z","timestamp":1792200986555,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005347","name":"American Association for the Study of Liver Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010377","name":"National Institute for Health and Care Excellence","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010377","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.clinre.2023.102261","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T12:31:12Z","timestamp":1701952272000},"page":"102261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cardiovascular outcomes post bariatric surgery in patients with metabolic dysfunction-associated steatotic liver disease - A systematic review and meta-analysis"],"prefix":"10.1016","volume":"48","author":[{"given":"Jai","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Mohsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6633-7577","authenticated-orcid":false,"given":"Misha","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdur Raheem","family":"Bilal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumail Mustafa","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Umer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dua Zehra Mohammad","family":"Hadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjna","family":"Nandlal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarwan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clinre.2023.102261_bib0001","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clinre.2023.102261_bib0002","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2023.102261_bib0003","doi-asserted-by":"crossref","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.clinre.2023.102261_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2016.01.008","article-title":"Relationship of epicardial fat thickness and nonalcoholic fatty liver disease to coronary artery calcification: from the Caesar Study","volume":"10","author":"Kim","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.clinre.2023.102261_bib0005","doi-asserted-by":"crossref","first-page":"33386","DOI":"10.1038\/srep33386","article-title":"Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: a systematic review and meta-analysis","volume":"6","author":"Wu","year":"2016","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.clinre.2023.102261_bib0006","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2023.102261_bib0007","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.cgh.2018.10.017","article-title":"Complete resolution of nonalcoholic fatty liver disease after bariatric surgery: a systematic review and meta-analysis","volume":"17","author":"Lee","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2023.102261_bib0008","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijcard.2014.02.026","article-title":"Bariatric surgery and its impact on cardiovascular disease and mortality: a systematic review and meta-analysis","volume":"173","author":"Kwok","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clinre.2023.102261_bib0009","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"7414","key":"10.1016\/j.clinre.2023.102261_bib0010","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.clinre.2023.102261_bib0011","unstructured":"Wells G.A., Shea B., O'Connell D., Peterson J., Welch V., Losos M., Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Available from: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"issue":"20","key":"10.1016\/j.clinre.2023.102261_bib0012","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/eurheartj\/ehac071","article-title":"Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis","volume":"43","author":"van Veldhuisen","year":"2022","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.clinre.2023.102261_bib0013","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.3390\/nu13103568","article-title":"Reduction of major adverse cardiovascular events (MACE) after bariatric surgery in patients with obesity and cardiovascular diseases: a systematic review and meta-analysis","volume":"13","author":"Sutanto","year":"2021","journal-title":"Nutrients"},{"issue":"oct22 1","key":"10.1016\/j.clinre.2023.102261_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f5934","article-title":"Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials","volume":"347","author":"Gloy","year":"2013","journal-title":"BMJ"},{"issue":"24","key":"10.1016\/j.clinre.2023.102261_bib0015","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1136\/heartjnl-2012-301778","article-title":"Bariatric surgery and cardiovascular outcomes: a systematic review","volume":"98","author":"Vest","year":"2012","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.clinre.2023.102261_bib0016","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s11695-013-1121-x","article-title":"Early impact of bariatric surgery on type II diabetes, hypertension, and hyperlipidemia: a systematic review, meta-analysis and meta-regression on 6,587 patients","volume":"24","author":"Ricci","year":"2013","journal-title":"Obes Surg"},{"issue":"20","key":"10.1016\/j.clinre.2023.102261_bib0017","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1161\/CIRCULATIONAHA.107.721027","article-title":"Effects of bariatric surgery on cardiovascular function","volume":"118","author":"Ashrafian","year":"2008","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.clinre.2023.102261_bib0018","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1381\/0960892041590980","article-title":"Ghrelin, leptin and insulin levels after restrictive surgery: a 2-year follow-up study","volume":"14","author":"Nijhuis","year":"2004","journal-title":"Obes Surg"},{"issue":"2","key":"10.1016\/j.clinre.2023.102261_bib0019","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.atherosclerosis.2005.02.014","article-title":"The potential role of resistin in atherogenesis","volume":"182","author":"Burnett","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinre.2023.102261_bib0020","first-page":"269","article-title":"Role of leptin in atherogenesis","volume":"11","author":"Dubey","year":"2006","journal-title":"Exp Clin Cardiol"},{"issue":"6","key":"10.1016\/j.clinre.2023.102261_bib0021","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1080\/03014460110048530","article-title":"The relationship of soluble ICAM-1, VCAM-1, P-selectin and E-selectin to cardiovascular disease risk factors in healthy men and women","volume":"28","author":"Demerath","year":"2001","journal-title":"Ann Hum Biol"},{"issue":"4","key":"10.1016\/j.clinre.2023.102261_bib0022","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2020.06.006","article-title":"Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis","volume":"159","author":"Lassailly","year":"2020","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.clinre.2023.102261_bib0023","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.clinre.2023.102261_bib0024","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement","volume":"7","author":"Neeland","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.clinre.2023.102261_bib0025","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.clinre.2023.102261_bib0026","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00125-016-3902-y","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"59","year":"2016","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.clinre.2023.102261_bib0027","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.soard.2021.11.015","article-title":"ASMBS position statement on the impact of metabolic and bariatric surgery on nonalcoholic steatohepatitis","volume":"18","author":"Mazzini","year":"2022","journal-title":"Surg Obes Related Dis"},{"issue":"30","key":"10.1016\/j.clinre.2023.102261_bib0028","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.3748\/wjg.v24.i30.3361","article-title":"Current guidelines for the management of non-alcoholic fatty liver disease: a systematic review with comparative analysis","volume":"24","author":"Leoni","year":"2018","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.clinre.2023.102261_bib0029","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3892\/br.2012.18","article-title":"Metformin in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"1","author":"Li","year":"2013","journal-title":"Biomed Rep"},{"issue":"1","key":"10.1016\/j.clinre.2023.102261_bib0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/hep.23623","article-title":"A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease","volume":"52","author":"Musso","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.clinre.2023.102261_bib0031","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the study of liver diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.clinre.2023.102261_bib0032","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1053\/j.gastro.2012.02.003","article-title":"Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications","volume":"142","author":"Cusi","year":"2012","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.clinre.2023.102261_bib0033","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.gastro.2008.03.078","article-title":"Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled fatty liver improvement with rosiglitazone therapy (FLIRT) trial","volume":"135","author":"Ratziu","year":"2008","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.clinre.2023.102261_bib0034","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/hep.23270","article-title":"Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial","volume":"51","author":"Ratziu","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clinre.2023.102261_bib0035","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/M15-1774","article-title":"Long-term pioglitazone treatment for patients with nonalcoholic steatohepatitis and prediabetes or type 2 diabetes mellitus: a randomized trial","volume":"165","author":"Cusi","year":"2016","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.clinre.2023.102261_bib0036","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/gut.2006.106021","article-title":"Weight loss induced by orlistat reverses fatty infiltration and improves hepatic fibrosis in obese patients with non-alcoholic steatohepatitis","volume":"56","author":"Assy","year":"2007","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.clinre.2023.102261_bib0037","first-page":"90","article-title":"Efficacy of orlistat in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"9","author":"Wang","year":"2018","journal-title":"Biomed Rep"},{"key":"10.1016\/j.clinre.2023.102261_bib0038","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.metabol.2017.08.010","article-title":"Pharmacotherapy of type 2 diabetes: an update","volume":"78","author":"Upadhyay","year":"2018","journal-title":"Metabolism"},{"issue":"10019","key":"10.1016\/j.clinre.2023.102261_bib0039","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.clinre.2023.102261_bib0040","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1007\/s00125-016-4100-7","article-title":"Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial","volume":"59","author":"Smits","year":"2016","journal-title":"Diabetologia"},{"issue":"18","key":"10.1016\/j.clinre.2023.102261_bib0041","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clinre.2023.102261_bib0042","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/13696998.2022.2026702","article-title":"Cost-effectiveness and potential value of pharmaceutical treatment of nonalcoholic fatty liver disease","volume":"25","author":"Rustgi","year":"2022","journal-title":"J Med Econ"},{"issue":"3","key":"10.1016\/j.clinre.2023.102261_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2021.03.017","article-title":"Effect of endoscopic bariatric and metabolic therapies on nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"20","author":"Jirapinyo","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2023.102261_bib0044","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/SLA.0000000000003871","article-title":"Bariatric surgery is associated with decreased progression of nonalcoholic fatty liver disease to cirrhosis","volume":"272","author":"Wirth","year":"2020","journal-title":"Ann Surg"},{"issue":"13","key":"10.1016\/j.clinre.2023.102261_bib0045","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/jama.2019.14231","article-title":"Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type 2 diabetes and obesity","volume":"322","author":"Aminian","year":"2019","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.clinre.2023.102261_bib0046","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.0047","article-title":"Cost-effectiveness analysis of bariatric surgery for patients with nonalcoholic steatohepatitis cirrhosis","volume":"2","author":"Klebanoff","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clinre.2023.102261_bib0047","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.942647","article-title":"Severity of nonalcoholic fatty liver disease is associated with cardiovascular outcomes in patients with prehypertension or hypertension: a community-based cohort study","volume":"13","author":"Song","year":"2022","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740123001869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740123001869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:35:01Z","timestamp":1761896101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740123001869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2210740123001869"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2023.102261","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular outcomes post bariatric surgery in patients with metabolic dysfunction-associated steatotic liver disease - A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2023.102261","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102261"}}